Robert Whitfield MD argues chronic inflammation drives most patient problems and criticizes mainstream medicine for ignoring genetics and energy medicine. He uses a proprietary stem-cell approach during fat transfer: harvesting a patient's stem cells, expanding them with a new device, then reinjecting them to speed healing.
Chapters
But there's really not an argument. There's just the reality is this happens from chronic inflammation. And then what do we need to do as providers, taking care of patients to get them to the other side of it? And what explanations need to be given, you know, for why it's happening now? I think part of it is we're pretty limited in allopathic medicine in general. We don't speak about genetics very much. It's like, not taboo, but not understood. We certainly don't have discussions about, you know, energy medicine. We don't have discussions about, you know, different ways to optimize, you know, pain control with our patients. We just don't do those things. And, you know, I get probably a little bit of stick for that because I'm constantly trying to figure out ways to help my patients. And I really don't care how much, you know, I have to invest in my business to get her the best results. So when we do her fat transfer, if that's what she chooses, the way to optimize her result is use my new stem cell device that we can take her stem cells out hers, expand them, and then we do her transfer, add more stem cells back, because your stem cells help you heal. But so it seems like in our country we're built to, like, not think outside the box anymore.